Article
Value of Genetically Rare Cord Blood Units Beyond Conventional Quality Metrics.
HLA - 1 Jul 2026
Selma-Soriano Estela, Valero-Hervás Diana, Boix Francisco, Planelles Dolores, Vera Belén, Vayá María Jesús, Arbona Cristina, Larrea Luis
Abstract excerpt
Allogeneic haematopoietic stem cell transplantation (HSCT) is a cornerstone therapy for haematological and genetic disorders. Owing to the limited availability of HLA-identical related donors, umbilical cord blood (UCB) has become a valuable alternative source of haematopoietic progenitors. However, many UCB units are excluded from banking based on quality criteria, despite potentially harbouring rare and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
